Galatea Bio (Series A)

Funding Details
Awarder
Inbox
Date Award
March 27, 2025
Vertical
Biotechnology
Funding URL
View Funding Page

Company Info
Founding Year
2021
Traction
Galatea Bio has established partnerships with health systems and industry leaders, including Illumina and Oxford Nanopore, to advance its biobank and genomic analysis capabilities.
Organizations Involved
Illumina, Oxford Nanopore, Baptist Health – South Florida
Founders
Carlos D. Bustamante, Ph.D.
Company Description
Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.
Market
Genomics and Precision Medicine
Location
Miami, Florida, USA
Coinvestors
F-Prime, Helios Digital Ventures, Digitalis Ventures, CEI Ventures, AME Cloud, Alexandria, Founders Collective, Stanford President’s Fund, HBM Genomics

Links
Back to Home Back to Biotechnology Deals View Funding Announcement